Cannabinoid Profile: CBD
Unfortunately, most cannabis strains in existence today are the results of generations of crossbreeding that has led to much higher potencies of THC while simultaneously leading to a diminished output of CBD. In fact, most modern cannabis strains contain less than 0.1% CBD. Luckily, renewed medical interest has led contemporary breeders to begin developing strains with higher CBD content, and there is an ever-growing number of those strains available today.
Below we present links to original research currently being carried out around the world into CBD's medical potential.
CBD Medical ResearchCancer: Cannabidiol as potential anticancer drug
Cancer: Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
Epilepsy: Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Schizophrenia: Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Stress: The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system